Bausch Health Companies Inc (BHC)
7.82
-0.27
(-3.34%)
USD |
NYSE |
May 03, 16:00
7.81
-0.01
(-0.13%)
After-Hours: 20:00
Bausch Health 1 Year Total Returns (Daily): 5.68% for May 3, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 03, 2024 | 5.68% |
May 02, 2024 | 10.07% |
May 01, 2024 | 16.51% |
April 30, 2024 | 18.86% |
April 29, 2024 | 20.49% |
April 26, 2024 | 23.37% |
April 25, 2024 | 21.07% |
April 24, 2024 | 13.23% |
April 23, 2024 | 10.78% |
April 22, 2024 | 9.74% |
April 19, 2024 | 15.40% |
April 18, 2024 | 15.28% |
April 17, 2024 | 13.20% |
April 16, 2024 | 16.69% |
April 15, 2024 | 15.22% |
April 12, 2024 | 18.70% |
April 11, 2024 | 17.72% |
April 10, 2024 | 19.25% |
April 09, 2024 | 26.33% |
April 08, 2024 | 32.20% |
April 05, 2024 | 40.30% |
April 04, 2024 | 33.11% |
April 03, 2024 | 28.72% |
April 02, 2024 | 25.93% |
April 01, 2024 | 28.40% |
Date | Value |
---|---|
March 28, 2024 | 42.03% |
March 27, 2024 | 40.81% |
March 26, 2024 | 36.38% |
March 25, 2024 | 31.12% |
March 22, 2024 | 26.12% |
March 21, 2024 | 19.95% |
March 20, 2024 | 26.02% |
March 19, 2024 | 25.53% |
March 18, 2024 | 23.42% |
March 15, 2024 | 20.58% |
March 14, 2024 | 14.77% |
March 13, 2024 | 16.58% |
March 12, 2024 | 14.45% |
March 11, 2024 | 13.57% |
March 08, 2024 | 7.08% |
March 07, 2024 | 7.41% |
March 06, 2024 | 4.65% |
March 05, 2024 | 4.37% |
March 04, 2024 | 4.59% |
March 01, 2024 | 7.27% |
February 29, 2024 | 0.86% |
February 28, 2024 | -1.18% |
February 27, 2024 | -1.61% |
February 26, 2024 | -6.06% |
February 23, 2024 | -6.80% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-84.55%
Minimum
Aug 02 2022
153.0%
Maximum
Mar 18 2021
-5.60%
Average
-6.28%
Median
Feb 27 2020
1 Year Total Returns (Daily) Benchmarks
Acasti Pharma Inc | 10.17% |
Aurinia Pharmaceuticals Inc | -56.37% |
Edesa Biotech Inc | -40.91% |
Lexaria Bioscience Corp | 93.21% |
Xenon Pharmaceuticals Inc | 7.28% |